Skip to main content

Table 1 Characteristics of the different study cohorts comprising healthy volunteers (HC), standard care patients with bacterial infections (SC), and intensive care unit (ICU) patients

From: Neutrophils are a main source of circulating suPAR predicting outcome in critical illness

 

HC

SC

ICU

ICU, sepsis

ICU, no sepsis

Number of patients

27

48

87

44

43

Male/female, n

12/15

33/15

55/32

24/20

31/12

Age median (range), years

33 (22–77)

65.5 (21–90)

65 (18–97)

68 (18–97)

58 (23–92)

Days in hospital, median (range)

–

6.0 (2.0–25.0)

12.0 (1.0–97.0)

11.5 (1.0–97.0)

12.0 (2.0–89.0)

Days on ICU, median (range)

–

–

5.0 (1.0–79.0)

5.0 (1.0–79.0)

5.0 (1.0–37.0)

Death on ICU, n (%)

–

–

25 (28.7)

15 (34.1)

10 (23.3)

APACHE II score, median (range)

–

–

25 (4–46)

26 (12–41)

23 (4–46)

Absence of shock, n (%)

–

–

56 (64)

31 (70.5)

25 (58.1)

Leukocytes median (range), × 103/μl

5.8 (3.8–8.9)

9.3 (2.1–23)

14.1 (0.5–41.9)

15.7 (0.5–42.9)

10.6 (2.7–31.4)

WBC Neutrophils median (range), %

56.4 (37.7–68.0)

78.4 (18.0–98.0)

87.7 (16.0–97.0)

90.3 (16.0–97.0)

86.0 (57.9–94.9)

WBC Monocytes median (range), %

7.2 (3.0–12.8)

7.0 (0.1–51.0)

4.7 (0.0–18.0)

4.1 (0.0–12.2)

6.4 (0.1–18.0)

WBC Lymphocytes median (range), %

32.2 (18.2–49.0)

11.6 (1.0–39.4)

4.7 (0.0–48.0)

3.8 (0.1–48.0)

6.6 (0.0–31.2)

CRP median (range), mg/l

–

86.8 (0.8–341.5)

66.6 (0.5–350.0)

135.5 (2.0–350.0)

37.4 (0.5–231.0)

PCT median (range), μg/l

–

–

1.0 (0.1–100.0)

2.18 (0.1–100.0)

0.8 (0.4–68.3)

ALT median (range), U/L

–

21.0 (5.0–84.0)

34.5 (5.0–9079.0)

26.0 (5.0–1280)

44.0 (6.0–9079.0)

AST median (range), U/L

–

32.0 (15.0–168.0)

53.5 (7.0–19,969.0)

36.0 (7.0–1178)

76.0 (14.0–19,969.0)

Gamma GT median (range) U/L

–

49.0 (8.0–636.0)

81.0 (8.0–168.0)

67.0 (4.0–781.0)

84.0 (9.0–1923)

ALP median (range), U/L

–

84.0 (35.0–286.0)

106.0 (19.0–530.0)

102.0 (39.0–350.0)

115.5 (19.0–530.0)

Bilirubin (total), mg/dl

–

0.64 (0.15–7.91)

0.78 (0.14–27.36)

0.64 (0.14–17.0)

1.0 (0.21–27.4)

Hb median (range), mmol/l

14.4 (12.7–16.0)

12.45 (7.1–17.5)

10.2 (5.6–16.1)

9.9 (7.0–16.1)

10.6 (5.6–15.5)

Creatinine median (range), mg/dl

–

0.96 (0.53–5.79)

1.5 (0.24–6.0)

1.6 (0.24–6.0)

1.9 (0.4–5.88)

GFR (range), ml/min

 

82.4 (8.5–139.8)

45.0 (6.0–167.4)

35.2 (6.0–130.6)

52.9 (7.3–167.4)

Urea (range), mg/dl

–

39.0 (11.0–182.0)

64.0 (10.0–233.0)

82.0 (26.0–233.0)

60.0 (10.0–213.0)

suPAR median (range), ng/ml

2.14 (0.0–3.5)

5.9 (2.1–24.1)

9.7 (0.38–38)

10.82 (0.38–38)

8.32 (1.54–38)

uPAR positive neutrophils median (range), % of neutrophils

94.7 (43.7–99.8)

87.7 (8.83–99.6)

58.3 (3.65–99.87)

51.6 (4.62–99.85)

60.9 (10.0–99.0)

  1. Abbreviations: ALP alkaline phosphatase, ALT/AST alanine/aspartate aminotransferase, APACHE II Acute Physiology And Chronic Health Evaluation, CRP C-reactive protein, GFR glomerular filtration rate, Hb hemoglobin, HC healthy control, ICU intensive care unit, SC standard care, PCT procalcitonin, (s)UPAR (soluble) urokinase plasminogen activation receptor, WBC white blood cell count
  2. The two right columns differentiate characteristics of ICU patients with or without sepsis